Ligand Pharmaceuticals Incorporated (LGND)
NASDAQ·Healthcare·Biotechnology
$286.22
-1.05%
Mkt Cap $5.72B
Analyst Ratings
Buy
12
Hold
0
Sell
0
Price Target (20 analysts)
$291.00
Range $252.00 – $332.00
Implied Upside
+1.7%
Consensus $291.00 vs current $286.22